1. Home
  2. ICL vs CAI Comparison

ICL vs CAI Comparison

Compare ICL & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

HOLD

Current Price

$5.38

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

CAI

Caris Life Sciences Inc.

HOLD

Current Price

$18.90

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICL
CAI
Founded
1968
2008
Country
Israel
United States
Employees
N/A
1846
Industry
Agricultural Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.9B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
ICL
CAI
Price
$5.38
$18.90
Analyst Decision
Hold
Strong Buy
Analyst Count
2
11
Target Price
$6.10
$30.91
AVG Volume (30 Days)
1.3M
1.7M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
3.19%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.04
$25.24
Revenue Next Year
$3.27
$22.32
P/E Ratio
$31.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.76
$16.28
52 Week High
$7.35
$42.50

Technical Indicators

Market Signals
Indicator
ICL
CAI
Relative Strength Index (RSI) 54.79 43.66
Support Level $5.23 $17.17
Resistance Level $5.51 $19.66
Average True Range (ATR) 0.12 1.00
MACD 0.01 -0.06
Stochastic Oscillator 45.97 21.72

Price Performance

Historical Comparison
ICL
CAI

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: